Paulo Fontoura

5PUBLICATIONS
73CO-AUTHORS
Biologically active moleculesMolecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.

Randall J Bateman, Yan Li, Eric M McDade

|May 11, 2024
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam.

Claudia A Chiriboga, Claudio Bruno, Tina Duong

|Apr 18, 2023
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA).

Maryam Oskoui, John W Day, Nicolas Deconinck

|Feb 03, 2023
Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA).

Maryam Oskoui, John W Day, Nicolas Deconinck

|May 03, 2019
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.

Federico Bolognani, Marta Del Valle Rubido, Lisa Squassante

Pageof 1

Frequent Collaborators

3 joint publications

Anna Kostera-Pruszczyk

3 joint publications

Renata S Scalco

3 joint publications

Eugenio Mercuri

3 joint publications

Heidemarie Kletzl